Vanguard Global Advisers’s Bio-Techne TECH Stock Holding History

Vanguard Global Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9M	Sell	324,090 -6,410	-2%	-$346K	0.01%	549
2026 Q1	$17.3M	Buy	+330,500	New	+$19.8M	0.01%	571

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Global Advisers's TECH Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Bio-Techne (TECH) stake by 1.9% in Q2 2026, selling an estimated $346K and leaving 324,090 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #549.

Vanguard Global Advisers first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 560 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Vanguard Global Advisers held 324,090 shares of Bio-Techne worth $22.9M as of Q2 2026.
Vanguard Global Advisers sold 6,410 Bio-Techne shares in Q2 2026, an estimated $346K.
Bio-Techne made up 0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #549 holding.
Vanguard Global Advisers first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
560 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.